Inhye E. Ahn1,7, Chingiz Underbayev2,7, Adam Albitar3, Sarah E. M. Herman2, Xin Tian4, Irina Maric5, Diane C. Arthur6, Laura Wake6, Stefania Pittaluga6, Constance M. Yuan6, Maryalice Stetler-Stevenson6, Susan Soto2, Janet Valdez2, Pia Nierman2, Jennifer Lotter2, Liqiang Xi6, Mark Raffeld6, Mohammed Farooqui2, Maher Albitar3, and Adrian Wiestner2
1 Medical Oncology Service, National Cancer Institute, Bethesda, MD; 2 Hematology Branch, National Heart, Lung, and Blood Institute, Bethesda, MD; 3 NeoGenomics Laboratories, Irvine, CA; 4 Office of Biostatistics Research, National Heart, Lung, and Blood Institute, Bethesda, MD; 5 Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, MD; 6 Laboratory of Pathology, National Cancer Institute, Bethesda, MD; 7 Inhye Ahn and Chingiz Underbayev contributed equally.
Corresponding author : Adrian Wiestner, M.D., Ph.D.
Hematology Branch, NHLBI, NIH Bld 10, CRC 3-5140, 10 Center Drive, 20892-1202, Bethesda, MD